Fosun Pharma repurchases shares, minor impact on issued capital
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKEX: 2196) announced today that it has repurchased 810,300 of its ordinary A shares on another stock exchange at prices ranging from RMB 24.63 to RMB 24.7 per share. The total aggregate price paid for the shares was RMB 19,998,413. Following the buyback, the number of treasury shares increased to 18,767,352, while the number of issued shares (excluding treasury shares) decreased to 2,099,721,473. The share repurchase represents a 0.04% change in the company's issued share capital (excluding treasury shares) and will be held as treasury shares. The company stated that the repurchases were made in accordance with the rules applying to repurchases on the other stock exchange.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical (Group) Co publishes news
Free account required • Unsubscribe anytime